(Q43682601)

English

Tandem high-dose chemotherapy in high-risk primary breast cancer: a multivariate analysis and a matched-pair comparison with standard-dose chemotherapy

scientific article published in January 2001

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Tandem high-dose chemotherapy in high-risk primary breast cancer: a multivariate analysis and a matched-pair comparison with standard-dose chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

based on heuristic

inferred from title

multivariate statistics

1 reference

based on heuristic

inferred from title

author name string

Schneeweiss A

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Goerner R

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Hensel MA

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Lauschner I

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sinn P

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Kaul S

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Egerer G

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Beldermann F

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Geberth M

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Solomayer E

10

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Grischke EM

11

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Haas R

12

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Ho AD

13

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Bastert G

14

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

332-342

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Cli

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980004-5

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980004-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980004-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980004-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980004-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980004-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the predictive value of Her-2/neu overexpression and p53 mutations in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980004-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Large‐bore central venous catheters for the collection of peripheral blood stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980004-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunomagnetic selection of CD34+ peripheral blood stem cells for autografting in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980004-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980004-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose: a critical factor in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980004-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow autotransplantation for solid tumors--prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980004-5

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4-9 involved axillary lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980004-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive chemotherapy with autologous bone marrow transfusion as primary treatment in women with breast cancer and more than five involved axillary lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980004-5

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survival

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980004-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980004-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980004-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980004-5

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy and peripheral blood progenitor cell transplantation in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980004-5

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980004-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1083-8791(01)80004-5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43682601&oldid=2102452635"